GL1X · GenesisL1 explorer

Research workbench

Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain

Analyse Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5V8R
Type
protein
Length
807 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a
EC
3.4.24.69
UniProt
P10845
Ligands
90J, ZN
Pockets
10 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein40232% helix, 18% strandP10845
BBotulinum neurotoxin type a (EC 3.4.24.69)protein40532% helix, 18% strandP10845

Ligands and binding sites

  • 90J · N-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]-2-sulfanylacetamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19050.760.7969empty
23540.640.7935ZN, 90J
32980.590.783390J
42610.570.7843empty
5570.520.8816empty

Interfaces

1 interface between chains.

  • A–B · 1837 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 5V8R · Small Molecule Inhibitor ABS-143 Bound to the Botulinum Neurotoxin Serotype A Light Chain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.